Clinical trial

A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide

NCT05414123

Study summary

ClinicalTrials.gov

A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide

Design: OBSERVATIONAL · Status: TERMINATED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention CNSide Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2022-09-07

PhaseN/A

Conditions

Leptomeningeal Metastasisverified · MONDO: neoplastic meningitis

Leptomeningeal Diseaseunresolved

Leptomeningeal Neoplasmsunresolved

Breast Cancerverified · MONDO: breast cancer

Non-Small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Interventions

CNSideDEVICE

Sponsors & collaborators

Biocept, Inc.lead sponsor

ICON plccollaborator

Mapped research locations

ChicagoIllinois, United States1 DallasTexas, United States1 SeattleWashington, United States1 StanfordCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05414123 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.